openPR Logo
Press release

Bone Biopsy Systems Market Size is Projected to Reach US$ 507.1 Million by 2035 With a CAGR of 6.3% | Fact.MR

04-25-2025 07:51 AM CET | Health & Medicine

Press release from: Fact.MR

Bone Biopsy Systems Market

Bone Biopsy Systems Market

The size of the bone biopsy systems market was USD 276.2 million in 2025. According to the Fact.MR report, the market for bone biopsy systems is set to increase at a 6.3% CAGR and will reach USD 507.1 million in 2035. The demand is being driven by the increase in the incidence rate of bone disease conditions such as metastatic bone cancer, osteomyelitis, lymphoma, and metabolic diseases such as osteoporosis in the world.

Early diagnosis and tissue differentiation have become significant in infectious disease and cancer diagnosis, and precision biopsy instruments have continued to have steady demand. Physicians are increasingly using bone biopsy systems enabling high diagnostic yield with minimal invasiveness.

For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=3884

Country-wise Analysis

The USA bone biopsy systems market is expected to grow at 7.2% CAGR during the study. Strong growth will be experienced with the high prevalence of bone disease, increasing geriatric population, and advancements in diagnostic imaging technology and minimally invasive techniques. Growing awareness regarding the importance of early detection of bone deformities such as osteoporosis and bone cancer has been a crucial factor in boosting the demand for biopsy systems.

The UK bone biopsy systems market will be expanding at 6.3% CAGR during the study period. This expansion is supported by the increasing rate of musculoskeletal disorders and growing incidence of cancer, which requires the utilization of diagnostic biopsies.

The South Korean bone biopsy systems market will advance at 6.5% CAGR between the forecast years. An aging population and growing incidence of bone cancers and metabolic bone diseases are fuelling robust demand for efficient diagnostic products.

The Australia-New Zealand bone biopsy systems market will be growing at 6.0% CAGR during the forecast period. The region's highly developed healthcare system and rising incidence of oncological and musculoskeletal diseases are driving the demand for precise diagnostic methods such as bone biopsies.

Segment-wise Analysis

By Use Case

Bone marrow biopsy will dominate the bone biopsy systems market by 2025 with a 60% share, while bone lesions biopsy takes up the other 40% of the share.

By Diagnostic Application

The bone disorder diagnosis segment will be the key driver of the bone biopsy systems market in 2025 and is anticipated to hold 28% of the overall revenue share. This segment will be trailed by Bone Cancer Diagnosis, which is anticipated to hold 25% of the remaining share.

By way of illustration

Stryker provides its OnControl® Bone Biopsy System, which patients would prefer to utilize for oncology, as it simplifies the retrieval of samples very easily while enhancing comfort. Furthermore, Argon Medical Devices produces a vast range of biopsy needles to diagnose bone cancer.

Competitive Outlook

The Bone Biopsy Systems Market is highly competitive with top medical device manufacturers and specialized diagnostic companies. Post-2024, players such as Becton, Dickinson and Company (BD), Stryker Corporation, Merit Medical Systems, Argon Medical Devices, and Cardinal Health became market leaders in product and geographic territory expansion.

BD solidified its leadership with the launch of the TruCore® Bone Marrow Biopsy System, which combines with the TruGuideTM Bone Access System that is supposed to increase procedural efficacy and safety. Stryker launched the OsteoScoop2 Bone Biopsy Needle, which offers enhanced visibility and stability to procedures. Merit Medical Systems launched the QuikCoreTM Bone Biopsy System to supplement its ACCESSTM Bone Biopsy System and strengthened its presence in the Asia-Pacific region through acquisitions.

Argon Medical Devices collaborated with Terumo India to market bone biopsy needles in India's rapidly growing market. Cardinal Health continues to lead the way in minimally invasive biopsy products that include bone marrow biopsy and aspiration needles.

Browse Full Report: https://www.factmr.com/report/3884/bone-biopsy-systems-market

Key Players

Becton, Dickinson and Company (BD)
Stryker Corporation
Merit Medical Systems
Argon Medical Devices
Cardinal Health
Cook Group Incorporated
Kimal PLC
Remington Medical
Mermaid Medical A/S
Laurane Medical

Segmentation

By Use Case:
Bone Marrow Biopsy
Bone Lesion Biopsy

By Diagnostic Application:
Bone Disorder Diagnosis
Bone Cancer Diagnosis
Bone Infection Detection
Chronic Kidney Disease Diagnosis
Others (Differentiating between Benign and Malignant Tumors)

By End-User:
Hospitals
Orthopedic Clinics
ASCs (Ambulatory Surgery Centers)

By Region:
North America
Latin America
Europe
East Asia
South Asia & ASEAN
Oceania
Middle East & Africa

Check out More Related Studies Published by Fact.MR:

Endoscopy Cameras Market
https://www.factmr.com/report/endoscopy-cameras-market
Air Ambulance Services Market
https://www.factmr.com/report/air-ambulance-services-market
Patient Positioning System Market
https://www.factmr.com/report/52/patient-positioning-market
Dental Consumables Market
https://www.factmr.com/report/4420/dental-consumables-market

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bone Biopsy Systems Market Size is Projected to Reach US$ 507.1 Million by 2035 With a CAGR of 6.3% | Fact.MR here

News-ID: 3987318 • Views:

More Releases from Fact.MR

Vanilla Extract Industry Analysis in South Asia & Oceania Growth to Reach US$ 910.64 Million at a CAGR of 7.7% by 2034 | Fact.MR
05-23-2025 | Food & Beverage
Fact.MR
Vanilla Extract Industry Analysis in South Asia & Oceania Growth to Reach US$ 91 …
The Revenue of vanilla extract industry in South Asia & Oceania is expected to grow from US$ 433.7 million in 2024 to US$ 910.64 million by 2034, at a 7.7% CAGR. Vanilla orchids, which produce vanilla beans, are cultivated primarily in tropical areas with specific soil and environmental conditions. Tahiti, Madagascar, and Comoros are some of the key areas that produce most of the world's vanilla. For More Insights into the Market,
Air Treatment Product Market Size Expected to Reach US$ 166.21 Billion by 2034: Fact.MR Report
Air Treatment Product Market Size Expected to Reach US$ 166.21 Billion by 2034: …
The size of the global air treatment products market has been estimated to grow to US$ 62.36 billion in 2024 and reach US$ 166.21 billion by the end of 2034. Demand for air treatment products at the global level is anticipated to grow at a healthy CAGR of 10.3% during 2024-2034. Air treatment products is a group of products and equipment that aim to enhance or sustain the indoor air quality.
Newborn Metabolic Screening Market is Predicted to Reach US$ 857.4 Billion by 2034, Expanding at a CAGR of 9.2% | Fact.MR
05-23-2025 | Health & Medicine
Fact.MR
Newborn Metabolic Screening Market is Predicted to Reach US$ 857.4 Billion by 20 …
The size of the newborn metabolic screening market is expected to reach US$ 355.1 million in 2024. A high compound annual growth rate (CAGR) of 9.2% is expected to drive the market through 2034. This upward trend is estimated to drive the market to a high value of US$ 857.4 million by 2034. As knowledge of metabolic disorders that impact infants has increased, so too has the use of newborn metabolic
Neuropathic Pain Market Size Worth US$ 14,538.7 Million by 2034 at a CAGR of 5.7% | Fact.MR
05-23-2025 | Health & Medicine
Fact.MR
Neuropathic Pain Market Size Worth US$ 14,538.7 Million by 2034 at a CAGR of 5.7 …
The size of the neuropathic pain market was approximately US$ 6,316.6 million in 2019. The net value of the neuropathic drugs to be retailed together with the nerve pain relief services is expected to be approximately US$ 8,382.9 million in 2024. The demand for the neuropathic pain relief medicines and services globally is expected to experience a CAGR of 5.7% during 2034. The industry is expected to be valued at

All 5 Releases


More Releases for Bone

Bone Substitute And Allograft Bone Market Size, Scope, Growth, Competitive Analy …
Precision Business Insights published a research report on "Bone Substitutes and Bone Allografts Market By Product Type (Bone Substitutes and Bone Allografts), By Bone Substitute Type (Hydroxyapatite (Hap), Calcium Phosphate, Calcium Sulphate, Bioactive Glass), By Bone Allograft Type (Freeze Dried and Demineralized Bone Matrix) - Global/Region/Country Forecast to 2028" Bone grafts and substitutes are used to replace missing bones and to treat fractures. They are made up of an osteoconductive matrix
Bone Graft Substitute Market Report 2018: Segmentation by Type (autograft, demin …
Global Bone Graft Substitute market research report provides company profile for ACE Surgical Supply Company, Inc., BioHorizons IPH, Inc., Dentium Co., Ltd., Dentsply Sirona, Institut Straumann AG, Medtronic plc, Stryker Corporation, Zimmer Biomet and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and
Bone Implant Market Gaining Momentum Worldwide - CT-Bone, 3D printed Bone Implan …
Market Highlights Bone implant products are used in numerous orthopedic surgeries to support the bone and to restore the functionality of the bone. The increasing geriatric population, growing number of orthopedic surgical procedures, rising prevalence of sports-related injuries, and bone weakness due to the changing lifestyle are the major factors driving the growth of the global bone implant market. Additionally, aggressive strategies adopted by top players and increasing spending on healthcare
Bone Biopsy Market 2018 | Needle Biopsy | Open Biopsy | Bone Cancer | Bone Infec …
The Global Bone Biopsy Market is growing continuously and expected to grow at a CAGR of 5.7% from 2017 to 2023. Bone biopsy is performed to diagnose various bone disorders such as bone cancer, bone infection, osteoporosis and chronic kidney disease. Nowadays, biopsy procedure has received great importance in oncology as one of the promising methods in cancer diagnostics. The demand for needle biopsy is found to be increasing from
Bone Replacement Products Market– Effective Solution for Bone Problems
The innovative replacement systems are designed to provide patients with a joint preservation ultimatum, preserving the healthy parts of the knee, thus helping to maintain natural knee function. For instance, in 2014, Cayenne Medical launched the Mirror Partial Knee System, the only knee replacement system that uses the patient’s natural knee motion during the surgical procedure. This unique technology balances the knee throughout the entire range of motion. The
Global Bone Densitometry Market: By Product Type - X-Ray Bone Densitometry & Ult …
Researchmoz added Most up-to-date research on "Global Bone Densitometry Market: By Product Type - X-Ray Bone Densitometry & Ultrasonic Bone Densitometry" to its huge collection of research reports. In this report, the global Bone Densitometry market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented